Victoria Woytowicz

Victoria Woytowicz is a skilled scientist with a strong background in neuroscience and biotechnology. Currently a Senior Associate Scientist I at Atalanta Therapeutics, Victoria focuses on designing and executing in vitro assays for siRNA therapeutics targeting neurodegenerative diseases. Previously, at Tevard Biosciences, Victoria held the position of Senior Research Associate I, concentrating on tRNA therapies for genetic disorders. Prior experiences include research at Yumanity Therapeutics on neurodegenerative diseases, work as a Research Associate at Axonis in spinal cord injury and neuropathic pain, and management roles at Schepens Eye Research Institute exploring genetic factors in Retinitis Pigmentosa. Victoria's initial career stage involved laboratory technology at VRL Eurofins Laboratories and research at the University of Massachusetts Boston, culminating in advanced degrees in Neuroscience from King's College London and Biology from UMass Boston.